Which statement about benzodiazepines is most accurate in anxiety treatment?

Which statement about benzodiazepines is most accurate in anxiety treatment?

• A. They are not first-line due to risk of dependence and withdrawal, especially with longer-term use or substance use history.
• B. They are the preferred long-term treatment
• C. They cure anxiety instantly
• D. They have no dependence risk

Answer: (A)

Benzodiazepines provide rapid relief from anxiety by enhancing the calming effects of GABA in the brain, which is why they can work quickly for acute symptoms. But their strong, fast-acting nature comes with a cost: a real risk of dependence and withdrawal. This risk grows the longer you use them and is especially concerning for people with a history of substance use. Because of these dangers, they’re not considered first-line for long-term anxiety management. Instead, for ongoing treatment, clinicians typically favor antidepressants such as SSRIs or SNRIs and often pair them with psychotherapy like CBT. Benzodiazepines may be used briefly as a bridge or for short-term relief in select situations, but they require careful monitoring and a plan to taper off to avoid withdrawal. So the statement that they are not first-line due to dependence and withdrawal risks—particularly with longer-term use or a substance use history—best captures their role in anxiety treatment.

Benzodiazepines provide rapid relief from anxiety by enhancing the calming effects of GABA in the brain, which is why they can work quickly for acute symptoms. But their strong, fast-acting nature comes with a cost: a real risk of dependence and withdrawal. This risk grows the longer you use them and is especially concerning for people with a history of substance use. Because of these dangers, they’re not considered first-line for long-term anxiety management. Instead, for ongoing treatment, clinicians typically favor antidepressants such as SSRIs or SNRIs and often pair them with psychotherapy like CBT. Benzodiazepines may be used briefly as a bridge or for short-term relief in select situations, but they require careful monitoring and a plan to taper off to avoid withdrawal. So the statement that they are not first-line due to dependence and withdrawal risks—particularly with longer-term use or a substance use history—best captures their role in anxiety treatment.